Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice
Xiaoyuan Bian,Wenrui Wu,Liya Yang,Longxian Lv,Qing Wang,Yating Li,Jianzhong Ye,Daiqiong Fang,Jingjing Wu,Xianwan Jiang,Ding Shi,Lanjuan Li
DOI: https://doi.org/10.3389/fmicb.2019.02259
IF: 5.2
2019-10-01
Frontiers in Microbiology
Abstract:Inflammatory bowel diseases (IBDs) develop as a result of complex interactions among genes, innate immunity and environmental factors, which are related to the gut microbiota. Multiple clinical and animal data have shown that <i>Akkermansia muciniphila</i> is associated with a healthy mucosa. However, its precise role in colitis is currently unknown. Our study aimed to determine its protective effects and underlying mechanisms in a dextran sulfate sodium (DSS)-induced colitis mouse model. Twenty-four C57BL/6 male mice were administered <i>A. muciniphila</i> Muc<sup>T</sup> or phosphate-buffered saline (PBS) once daily by oral gavage for 14 days. Colitis was induced by drinking 2% DSS from days 0 to 6, followed by 2 days of drinking normal water. Mice were weighed daily and then sacrificed on day 8. We found that <i>A. muciniphila</i> improved DSS-induced colitis, which was evidenced by reduced weight loss, colon length shortening and histopathology scores and enhanced barrier function. Serum and tissue levels of inflammatory cytokines and chemokines (TNF-α, IL1α, IL6, IL12A, MIP-1A, G-CSF, and KC) decreased as a result of <i>A. muciniphila</i> administration. Analysis of 16S rDNA sequences showed that <i>A. muciniphila</i> induced significant gut microbiota alterations. Furthermore, correlation analysis indicated that pro-inflammatory cytokines and other injury factors were negatively associated with <i>Verrucomicrobia</i>, <i>Akkermansia, Ruminococcaceae</i>, and <i>Rikenellaceae</i>, which were prominently abundant in <i>A. muciniphila</i>-treated mice. We confirmed that <i>A. muciniphila</i> treatment could ameliorate mucosal inflammation either via microbe-host interactions, which protect the gut barrier function and reduce the levels of inflammatory cytokines, or by improving the microbial community. Our findings suggest that <i>A. muciniphila</i> may be a potential probiotic agent for ameliorating colitis.
microbiology